CAS 566-75-6
:16-Cetoestradiol
- (17Beta)-3,17-Dihydroxyestra-1,3,5(10)-Trien-16-One
- (17β)-3,17-Dihydroxyestra-1,3,5(10)-trien-16-one
- (1Beta,3Alpha,5Beta,7Alpha)-1,3,7-Trihydroxycholan-24-Oic Acid
- (2R,3R)-3-hydroxy-2-methylbutanoic acid
- (3Alpha,5Beta,12Beta)-3,12-Dihydroxycholan-24-Oic Acid
- (3Beta,5Alpha,17Alpha)-Androstane-3,17-Diol
- (5R)-5-hydroxyhexanoic acid
- 1,3,5(10)-Estratriene-3,17β-diol-16-one
- 16-Oxo-17β-estradiol
- 16-Oxoestradiol
- 16-Oxoestradiol-17β
- 16-keto-17β-Estradiol
- 3,17-Beta-Dihydroxyoestra-1,3,5(10)-Trien-16-One
- 3,17β-Dihydroxyestra-1,3,5(10)-trien-16-one
- 3-Hydroxydodecanedioic Acid
- Estra-1,3,5(10)-trien-16-one, 3,17-dihydroxy-, (17β)-
- Estra-1,3,5(10)-trien-16-one, 3,17β-dihydroxy-
- NSC 51169
- Ver mais sinónimos
16-Keto-17β-estradiol-2,4,15,15,17-d5
CAS:Pureza:95 atom % DCor e Forma:White-Yellow SolidPeso molecular:291.4016-Keto 17b-Estradiol (>85%)
CAS:Produto ControladoApplications A metabolite of Estradiol (E888000).
References Ball, P., et al.: Steroids, 33, 563 (1979), Wong, T., et al.: Clin. Chem., 38, 1830 (1992), Xu, X., et al.: J. Clin. Endocrinol. Metab., 84, 3914 (1999), Todorovic, R., et al.: Carcinogenesis, 22, 905 (2001), Travis, R., et al.: Breast Cancer Res., 5, 239 (2003),Fórmula:C18H22O3Pureza:>85%Cor e Forma:NeatPeso molecular:286.3716-Keto 17beta-Estradiol-d5 (Major)
CAS:Produto ControladoApplications A labelled metabolite of Estradiol (E888000).
References Ball, P., et al.: Steroids, 33, 563 (1979), Wong, T., et al.: Clin. Chem., 38, 1830 (1992), Xu, X., et al.: J. Clin. Endocrinol. Metab., 84, 3914 (1999), Todorovic, R., et al.: Carcinogenesis, 22, 905 (2001), Travis, R., et al.: Breast Cancer Res., 5, 239 (2003),Fórmula:C18H17D5O3Cor e Forma:NeatPeso molecular:291.416-Keto-17β-estradiol
CAS:Produto Controlado16-Keto 17b-estradiol (16KE) is a potent estrogen that binds to the estrogen receptor and inhibits the binding of other estrogens. 16KE has been shown to be effective in inhibiting the growth of Streptococcus faecalis, which is often found in urine samples or as a result of bacterial vaginosis. 16KE also has an anti-angiogenic effect, which may be due to its ability to inhibit angiogenic factors such as vascular endothelial growth factor and angiopoietin 2. 16KE also has hormonal effects on adrenocortical carcinoma cells, leading to decreased cell proliferation and increased apoptosis. This compound may also have an anti-cancer effect by inducing apoptosis and suppressing tumor growth through the inhibition of cancer cell proliferation and stimulation of cancer cell death.
Fórmula:C18H22O3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:286.37 g/molRef: 3D-FK24760
Produto descontinuado





